Etanercept Completed Phase 2 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00141713The Use of Etanercept (EnbrelĀ®) in the Treatment of Acute Graft-Versus-Host Disease
NCT00141739Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)